EcoDrugPlus

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSHBUG00000008138
Gene Symbol: GHRHR
2 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSHBUG00000015039
Gene Symbol: GHSR
3 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSHBUG00000009268
Gene Symbol: GUCY1A1
3 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSHBUG00000011941
Gene Symbol: GUCY1A2
4 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSHBUG00000009225
Gene Symbol: GUCY1B1
3 Cross references
210 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSHBUG00000018394
Gene Symbol: HSP90AB1
3 Cross references
339 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha

Ensembl ID : ENSHBUG00000022372
Gene Symbol: LOC102312058
3 Cross references
345 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha 1

Ensembl ID : ENSHBUG00000022200
Gene Symbol: LOC102312375
3 Cross references
330 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSHBUG00000002784
Gene Symbol: LOC102292579
3 Cross references
509 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSHBUG00000006001
Gene Symbol: LOC102300309
2 Cross references
511 Possible Orthologues:

Histamine H2 Receptor-Like

Ensembl ID : ENSHBUG00000009779
Gene Symbol: LOC102305319
3 Cross references
189 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSHBUG00000010014
Gene Symbol: HRH1
4 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).